EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

AI ‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors

Seid Miad Zandavi iD, Christy Kim, Thomas Goodwin, Cynthuja Thilakanathan, Maryam Bostanara iD, Anna Camille Akon, Daniel Al Mouiee iD, Sasha Barisic, Ammar Majeed iD, William Kemp iD, Francis Chu, Marty Smith iD und 8 weitere

Liver International · 2024-10 · 44 (10) · 2724-2737

DOI: 10.1111/liv.16050 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 24.07.2024. Verfasst von Seid Miad Zandavi und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local, Artificial Intelligence. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) recurrence following surgical resection remains a significant clinical challenge, necessitating reliable predictive models to guide personalised interventions. In this study, we sought to harness the power of artificial intelligence (AI) to develop a robust predictive model for HCC recurrence using comprehensive clinical datasets.

Methods

Leveraging data from 958 patients across multiple centres in Australia and Hong Kong, we employed a multilayer perceptron (MLP) as the optimal classifier for model generation.

Results

Through rigorous internal cross‐validation, including a cohort from the Chinese University of Hong Kong (CUHK), our AI model successfully identified specific pre‐surgical risk factors associated with HCC recurrence. These factors encompassed hepatic synthetic function, liver disease aetiology, ethnicity and modifiable metabolic risk factors, collectively contributing to the predictive synergy of our model. Notably, our model exhibited high accuracy during cross‐validation (.857 ± .023) and testing on the CUHK cohort (.835), with a notable degree of confidence in predicting HCC recurrence within accurately classified patient cohorts. To facilitate clinical application, we developed an online AI digital tool capable of real‐time prediction of HCC recurrence risk, demonstrating acceptable accuracy at the individual patient level.

Conclusion

Our findings underscore the potential of AI‐driven predictive models in facilitating personalised risk stratification and targeted interventions to mitigate HCC recurrence by identifying modifiable risk factors unique to each patient. This model aims to aid clinicians in devising strategies to disrupt the underlying carcinogenic network driving recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalArtificial IntelligenceHumansRisk FactorsFemaleMaleHong KongMiddle AgedAustraliaAgedRisk AssessmentHepatectomyPrecision Medicine

Stichwörter der Autor:innen

artificial intelligenceliver cancerpredictive modelssurgical resectionsurvival analyses

Autor:innen und Institutionen

  • School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • UNSW Data Science Hub, University of New South Wales, Sydney, New South Wales, Australia.
  • St George and Sutherland Clinical Campuses, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Gastroenterology and Hepatology, St George Hospital, Sydney, New South Wales, Australia.
  • Department of Gastroenterology and Hepatology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • The Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

ORCID-Profile: Seid Miad Zandavi, Maryam Bostanara, Daniel Al Mouiee, Ammar Majeed, William Kemp, Marty Smith, Kate Collins, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Stuart K Roberts, Kelvin K C Ng, Fatemeh Vafaee, Amany Zekry

Zitieren

APA

Zandavi, S. M., Kim, C., Goodwin, T., Thilakanathan, C., Bostanara, M., Akon, A. C., Al Mouiee, D., Barisic, S., Majeed, A., Kemp, W., Chu, F., Smith, M., Collins, K., Wong, V. W., Wong, G. L., Behary, J., Roberts, S. K., Ng, K. K. C., Vafaee, F., & Zekry, A. (2024). AI ‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors. Liver International, 44(10), 2724-2737. https://doi.org/10.1111/liv.16050

Vancouver

Zandavi SM, Kim C, Goodwin T, Thilakanathan C, Bostanara M, Akon AC, et al. AI ‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors. Liver International. 2024;44(10):2724-2737. doi:10.1111/liv.16050

BibTeX
@article{Zandavi2024,
  author = {Zandavi, Seid Miad and Kim, Christy and Goodwin, Thomas and Thilakanathan, Cynthuja and Bostanara, Maryam and Akon, Anna Camille and Al Mouiee, Daniel and Barisic, Sasha and Majeed, Ammar and Kemp, William and Chu, Francis and Smith, Marty and Collins, Kate and Wong, Vincent Wai-Sun and Wong, Grace Lai-Hung and Behary, Jason and Roberts, Stuart K and Ng, Kelvin K C and Vafaee, Fatemeh and Zekry, Amany},
  title = {AI ‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {10},
  pages = {2724--2737},
  doi = {10.1111/liv.16050}
}
Kostenlos starten →